These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30634986)

  • 21. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G; Collins AB; McNeil R; Boyd J
    Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing Use of Supervised Consumption Services among Street-involved Youth and Young Adults in the Context of an Overdose Crisis.
    Lee-Pii K; DeBeck K; Choi J; Sedgemore KO; Kerr T; Kennedy MC
    J Urban Health; 2024 Apr; 101(2):233-244. PubMed ID: 38536600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective client survey and participatory process ahead of opening a mobile drug consumption room in Lisbon.
    Taylor H; Curado A; Tavares J; Oliveira M; Gautier D; Maria JS
    Harm Reduct J; 2019 Aug; 16(1):49. PubMed ID: 31399097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
    Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
    Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
    J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peer-led safer supply and opioid agonist treatment medication distribution: a case study from rural British Columbia.
    Scow M; McDougall J; Slaunwhite A; Palis H
    Harm Reduct J; 2023 Oct; 20(1):156. PubMed ID: 37875927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using mobile clinics to deliver HIV testing and other basic health services in rural Malawi.
    Lindgren TG; Deutsch K; Schell E; Bvumbwe A; Hart KB; Laviwa J; Rankin SH
    Rural Remote Health; 2011; 11(2):1682. PubMed ID: 21787108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.
    Speed KA; Gehring ND; Launier K; O'Brien D; Campbell S; Hyshka E
    Harm Reduct J; 2020 Oct; 17(1):72. PubMed ID: 33028363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "It's just not the same": Exploring PWUD' perceptions of and experiences with drug policy and SCS services change in a Canadian City.
    Greene C; Maier K; Urbanik MM
    Int J Drug Policy; 2023 Jan; 111():103934. PubMed ID: 36549200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accessibility gaps of physical supervised consumption sites in Canada motivating the use of overdose response technology/phone based virtual overdose response services: a retrospective cohort study.
    Mocanu V; Viste D; Rioux W; Ghosh SM
    Lancet Reg Health Am; 2024 Jun; 34():100770. PubMed ID: 38798948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "The system always undermined what I was trying to do as an individual": identifying opportunities to improve the delivery of opioid use services for youth from the perspective of service providers in four communities across British Columbia, Canada.
    Marchand K; Turuba R; Katan C; Fogarty O; Fairbank J; Tallon C; Mathias S; Barbic S
    Addict Sci Clin Pract; 2023 Jan; 18(1):1. PubMed ID: 36593469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services.
    Ivsins A; Warnock A; Small W; Strike C; Kerr T; Bardwell G
    Int J Drug Policy; 2023 Jan; 111():103910. PubMed ID: 36436364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.
    Young S; Fairbairn N
    Can J Public Health; 2018 Apr; 109(2):227-230. PubMed ID: 29981039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of health care utilization among people who overdosed from illegal drugs: a descriptive analysis using the BC Provincial Overdose Cohort.
    Otterstatter MC; Crabtree A; Dobrer S; Kinniburgh B; Klar S; Leamon A; May-Hadford J; Mill C; Park M; Tu AW; Zheng L
    Health Promot Chronic Dis Prev Can; 2018 Sep; 38(9):328-333. PubMed ID: 30226726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent Alcohol and Opioid Use Among Harm Reduction Clients.
    Winstanley EL; Stover AN; Feinberg J
    Addict Behav; 2020 Jan; 100():106027. PubMed ID: 31683186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Another tool in the toolkit"-Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site.
    Perlmutter D; Wettemann C; Fockele CE; Frohe T; Williams W; Holland N; Oliphant-Wells T; Meischke H; van Draanen J
    Int J Drug Policy; 2023 May; 115():104005. PubMed ID: 36972652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.